Traders Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading on Wednesday. Traders purchased 1,885 put options on the company. This represents an increase of 1,101% compared to the average volume of 157 put options.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Walleye Capital LLC acquired a new position in shares of Evelo Biosciences during the first quarter valued at $38,000. Shay Capital LLC acquired a new position in Evelo Biosciences during the fourth quarter worth about $30,000. Barclays PLC grew its holdings in Evelo Biosciences by 654.2% during the fourth quarter. Barclays PLC now owns 22,641 shares of the company’s stock worth $36,000 after acquiring an additional 19,639 shares during the period. Cresset Asset Management LLC grew its holdings in Evelo Biosciences by 200.0% during the first quarter. Cresset Asset Management LLC now owns 30,000 shares of the company’s stock worth $102,000 after acquiring an additional 20,000 shares during the period. Finally, Man Group plc acquired a new position in Evelo Biosciences during the fourth quarter worth about $85,000. 0.31% of the stock is owned by institutional investors and hedge funds.

Evelo Biosciences Stock Performance

Shares of EVLO opened at $0.05 on Friday. The firm has a market capitalization of $949,000.00, a price-to-earnings ratio of 0.00 and a beta of 2.03. Evelo Biosciences has a one year low of $0.03 and a one year high of $13.93. The stock’s fifty day moving average is $0.05 and its 200-day moving average is $0.42.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.